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LITERATURE REVIEW 
 As individuals age, there are several physical changes that occur. These changes include 
a decrease in height due to spinal compression, an increase in weight due to reduced metabolism 
changes and decreased physical activity, and loss of bone and muscle due to hormonal changes 
and physical inactivity.  Additionally, older adults typically experience weight gain through the 
accumulation of harmful adipose tissue rather than an increase in muscle mass.  In 2008, there 
were 1.46 billion adults worldwide who were classified as overweight, as determined by an 
analysis of 199 countries. Of these overweight adults, 502 million were classified as being obese 
(Wang, McPherson, Marsh, Gortmaker & Brown, 2011).  This obesity epidemic is extremely 
important because obesity is directly related to negative health consequences such heart disease, 
stroke, type II diabetes, and some cancers; all of which can be debilitating and negatively impact 
quality of life (Mittal, Goyal, Dasude, Quazi, & Basak, 2011). Obesity also contributes 
significantly to annual medical costs, estimated at between 4 and 7% of the total health care bill 
in the United States (equivalent to roughly $75 billion in 2003) (Wang, McPherson, Marsh, 
Gortmaker & Brown, 2011).  In the next two decades, a study predicts that, following historical 
tendencies, 8 million cases of diabetes, 6-8 million cases of coronary heart disease or stroke, and 
500,000 cases of cancers will arise due to obesity-related complications (Wang, McPherson, 
Marsh, Gortmaker & Brown, 2011).  Thus, the obesity epidemic has significant implications on 
health as well as economics. 
In addition to the aforementioned body changes, many older adults also experience 
sarcopenia, loosely defined as the progressive deterioration and loss of muscle mass within the 
body, often accompanied with impaired muscle functioning and strength.  This decline in muscle 
tissue can begin as early as the fourth decade of life (McIntosh, Smale & Vallis, 2013).  
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Sarcopenia can also be classified into two areas: primary or secondary.  Primary sarcopenia is 
solely due to the normal aging process, whereas secondary sarcopenia also includes lifestyle 
variations, diseases, and nutritional factors that may additively contribute to the extent of 
sarcopenia in the individual (Cruz-Jentoft, 2013).   
However, studies show widely variability in the prevalence of sarcopenia in older adults, 
likely due to the lack of a measurable clinical definition of sarcopenia.  Conflicting data reports 
the prevalence of sarcopenia ranging from 6% (McIntosh, Smale & Vallis, 2013) to 55% 
(Krause, McIntosh & Vallis, 2012).  Yet another study found the prevalence of sarcopenia in the 
60-70 year old age group to be 5-13% and in the 80+ age group to be 11-50% (Cruz-Jentoft et. 
al., 2010).  There is a push to create a clinical definition of sarcopenia based on two primary 
criteria: a loss of muscle mass and an associated loss of strength and functionality (Cruz-Jentoft 
et. al., 2010). A clinical protocol for the assessment of sarcopenia is important because 
sarcopenia is associated with decrease mobility, increased falls (and resulting bone fractures), 
difficulties performing activities of daily living (ADLs), disability, and more (Cruz-Jentoft et. al, 
2010). 
Thus, changes in body composition may include 1) increased fat mass alone, 2) decreased 
muscle mass alone, or 3) a combination of both increased fat mass and decreased muscle mass.  
With this range of possibilities, techniques to assess body composition become a vitally 
important means of assessing risk for health complications and diseases in the older population.  
The third of these listed options is prevalent in the elderly population and has been described as 
sarcopenic obesity (Cruz-Jentoft et. al, 2010).  The fat gained in later life is typically 
intramuscular and visceral. This visceral and intramuscular fat is associated with an increase in 
obesity related diseases because it is concentrated around the internal organs and places added 
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stress on their functioning.  As the obesity epidemic continues, it is vital to keep track of levels 
of sarcopenia as well.  Conservative estimates hypothesize that there will be over 200 million 
people who experience sarcopenia over the next 40 years (Cruz-Jentoft et. al, 2010).  This can 
lead to significant and dramatic increases in health challenges and complications faced by older 
adults, stressing the need for methods to assess body composition. 
BODY MASS INDEX (BMI) 
 Currently, the most commonly used tool to assess health risk is the body mass index 
(BMI).  BMI is computed from one’s weight in kilograms divided by their height in meters 
squared.  On a population level, BMI is linked to health risks and complications associated with 
obesity as listed previously.  The cutoffs for BMI, according to the Center for Disease Control’s 
standards, are: less than 18.5 kg/m
2
 (underweight), 18.5-24.9 kg/m
2
 (normal), 25-29.9 kg/m
2
 
(overweight), and greater than 30 kg/m
2
 (obese) (About BMI for Adults, 2011).   
BMI’s originally intended purpose was for population-based analysis, but due to the 
simplicity of this method, BMI gained popularity in individual diagnosis as well. However, BMI 
has faced much scrutiny, as it does not directly measure fat, but is merely a mathematical 
formula that is associated with body composition but in no way directly assesses it.  Potential 
problems associated with BMI scores are that men tend to have higher BMIs than women and 
older adults tend to have higher BMIs than children and young adults (About BMI for Adults, 
2011).  Studies have shown that there was no correlation between BMI and either cardiovascular 
disease mortality or all-cause mortality, likely due to the fact that BMI does not reflect the 
amount of dangerous abdominal visceral fat (Hollander, Bemelmans & Groot, 2013). A 
systematic review of current literature discussed two significant reasons why BMI is not an 
appropriate predictor of mortality: it lacks the ability to discern between fat mass and fat free 
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mass, and the height measurements may be unreliable due to shrinkage and vertebral collapse 
(Chang, Beason, Hunleth & Colditz, 2012).  This same systematic review also found BMI to be a 
negative predictor of several health consequences including metabolic syndrome (Chang, 
Beason, Hunleth & Colditz, 2012).   
RESEARCH PROBLEM 
With many sources questioning the validity and usefulness of BMI, why is it still being 
utilized so prevalently?  The main reason is due to its simplicity and its ability to assess and 
generalize large populations.  However, there are many ways to assess body fat; either through 
anthropometric means such as waist circumference (WC) and sagittal abdominal diameter (SAD) 
or body compositional methodologies such as bioelectrical impedance activity (BIA) or air 
displacement plethysmography (ADP).  This study seeks to compare the accuracy, relevancy, 
and appropriateness of some of these methods in order to justify the use of some methods in 
preference over others.  The following sections detail some of the most well-known 
methodologies in assessing body composition and obesity. 
WAIST CIRCUMFERENCE (WC) 
 Waist circumference (WC) is the simple measure of a subject’s waist either at its 
narrowest point or at the umbilicus with a Gulick tape measure (Figure 1).  WC is an important 
tool because it measures the human trunk.  As we age, the locations of fat on the body change 
and tend to accumulate in the abdominal region.  Due to this shift in body fat distribution from 
subcutaneous fat (under the skin) to visceral fat (around the internal organs), this study showed 
WC to be more relevant than other circumference measurements such as the arm or the calf 
(Krause, McIntosh & Vallis, 2012). This visceral fat is extremely dangerous to one’s health, 
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particularly for its impact on the internal organs in the abdomen such as the heart, liver, and 
kidneys.    
Waist circumference classifies men as either at normal risk or at high risk for health 
complications. Men with a WC of over 102 centimeters (40 inches) are classified as high risk.  In 
a study of 2080 participants, a decrease of WC of more than 3.1 centimeters was significantly 
associated with cardiovascular disease mortality and an increase in WC of between 3.1 and 6.9 
centimeters was associated with an increased likelihood of all-cause mortality (Hollander, 
Bemelmans & Groot, 2013).   
   
 
Figure 1.  Measuring tape position for waist circumference.  High disease risk is >102 cm (> 40 
in) for men and > 88 cm ( > 35 in) for women.  Image from: 
http://www.nhlbi.nih.gov/guidelines/obesity/e_txtbk/txgd/4142.htm.  Guidelines from: 
National Institutes of Health’s Clinical Guidelines on the Identification, Evaluation, and 
Treatment of Overweight and Obesity in Adults: the Evidence Report (Obes Res. 1998; 6: (suppl 
2): 51S–209S). 
 
  A 2012 systematic review by Chang, Beason, Hunleth & Colditz discussed the 
association between visceral fat accumulation and health consequences such as metabolic 
syndrome, inflammation, and dyslipidemia in which waist circumference has a positive 
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association (Chang, Beason, Hunleth & Colditz, 2012).  This same review of 2702 citations 
found waist circumference to overcome the obesity paradox better than BMI assessment.  The 
obesity paradox is a phenomenon in which overweight and obese subjects actually have better 
survival outcomes than the normal weight category (even though due to their overweight/obesity 
they are more likely to face mortality-related diseases) (Chang, Beason, Hunleth & Colditz, 
2012).  Other studies also determined the link between waist circumference, type II diabetes, and 
metabolic syndrome (Duren, Sherwood, Czerwinski, Lee, Choh, Siervogel, & Chumlea, 2008). 
 A study of 2032 Chinese subjects compared waist circumference at specific BMI levels 
(of 25 and 30 kg/m
2
) in the older population with those of a younger reference population (Woo, 
Ho, Yu & Sham, 2002).  This study found that older adults at with the same BMI as younger 
adults had significantly larger measurements of waist circumference (approximately 6.0 cm) 
(Woo, Ho, Yu & Sham, 2002).  Another study also compared BMI and WC in a 12 year 
longitudinal study of 1780 subjects over 65 years in age.  This study showed that WC was 
associated with mortality in all older adults, with even stronger associations among individuals 
with congestive heart failure (CHF) (Testa, Cacciatore, Galizia, Della-Morte, Mazzella, 
Langellotto, Russo, Gargiulo, De Santis, Ferrara, Rengo & Abete, 2010).  This study determined 
that each centimeter increase in WC was linked to a 2% increase in long-term mortality risk in 
those without CHF and a 5% increase in those with CHF.  This study also concluded that WC 
helped to eliminate the obesity paradox in comparison to BMI (Testa et. Al, 2010).  
SAGITTAL ABDOMEN DIAMETER (SAD) 
Sagittal abdomen diameter (SAD) is very similar to WC, except that in SAD the subject 
is in a supine position rather than an upright standing position. (Figure 2). The importance in this 
change of positioning for measurement is so the subcutaneous fat will not slide to the sides of the 
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waist as in the WC method (Pimentel, Moreto, Takahashi, Poreto-McLellan & Burini, 2011).  
This method has many of the same correlations as WC and additionally is more strongly 
associated with dyslipidemia and hyperglycemia (Pimentel, Moreto, Takahashi, Poreto-McLellan 
& Burini, 2011). Another study determined SAD to have stronger correlations in women than in 
men (Pimentel, Portero-McLellan, Maestá, Corrente & Burini, 2010).  In a study of middle-aged 
adults, SD was shown to correlate strongly to a multitude of heart disease risk factors (Pimentel, 
Moreto, Takahashi, Poreto-McLellan & Burini, 2011).  SAD can also be measured with a ruler 
or a caliper system which allow for easy measurement and reliability (Pimentel, Moreto, 
Takahashi, Poreto-McLellan & Burini, 2011).  SAD results, measured with a sliding beam 
caliper have been shown to have good reproducibility and have been shown to be accurate in 
comparison to computer tomography scans (CT scans) (Öhrvall, Berglund & Vessby, 2000) (Parr 
& Haigh, 2006).   
 
Figure 2.  Sagittal abdomen diameter.  Image from: 
http://www.absoluteastronomy.com/topics/Sagittal_Abdominal_Diameter, 
 
BIOELECTRICAL IMPEDANCE ANALYSIS (BIA) 
Bioelectrical impedance analysis (BIA) is a body composition test performed by sending 
electrical pulses through the body briefly (Figure 3).  Different body tissues have variable 
electrical conductivity and thus different impedance (Mittal, Goyal, Dasude, Quazi, & Basak, 
2011).  Muscle and water have low impedance whereas adipose fat has high impedance (Mittal, 
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Goyal, Dasude, Quazi, & Basak, 2011).  Issues with accuracy in BIA come from the sensitivity 
of the test to water and electrolyte levels within the body (Krause, McIntosh & Vallis, 2012).  
Older adults tend to carry more water weight, which influences the effectiveness of this test.    
 
Figure 3. Bioelectrical impedance analysis.  Image from: http://www.medi-
shop.gr/en/MedicalDevices/Body-fat-monitors/inbody-230.   
 
 Bioelectrical impedance analysis has been shown to be significantly more accurate at 
assessing body composition than BMI.  In a study of 276 subjects from India, 3.9% of men and 
5.7% of women were considered obese through BMI and 52.9% of men and 52.9% of women 
were considered obese through BIA (Mittal, Goyal, Dasude, Quazi, & Basak, 2011).  BIA tends 
to be more efficient than anthropometric methods, because it is based on a two compartment 
model of distinguishing between fat mass and fat-free mass (Chang, Beason, Hunleth & Colditz, 
2012).  Another study shows that BIA, like BMI, can be useful in large groups of individuals, but 
that individual variance with BIA can be high (Duren, Sherwood, Czerwinski, Lee, Choh, 
Siervogel, & Chumlea, 2008).   
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AIR DISPLACEMENT PLETHYSMOGRAPHY (ADP) 
 Air displacement plethysmography (ADP) also uses the same two compartment model as 
BIA.  ADP was created as an alternative to the “gold standard” of body composition methods: 
hydrodensitometry or “underwater weighing” (UWW).  UWW had complications with 
compliance because of the taxing physical strain (submerging oneself underwater and exhaling 
subject’s lungs to the greatest possible extent) that it can take on subjects, which is particularly 
relevant to testing with older adults (Alemán-Mateo, Romero, Macías Morales, Salazar, Triana & 
Valencia, 2004; Testa, Cacciatore, Galizia, Della-Morte, Mazzella, Langellotto, Russo, Gargiulo, 
De Santis, Ferrara, Rengo & Abete, 2010).  ADP is less physically demanding and the process of 
assessment is quicker as a whole (Alemán-Mateo et. al., 2004). ADP uses the same formulas as 
UWW (e.g., Siri and Brozek) since they both are volumetric measures.  Even though ADP 
appears to have several benefits over UWW, ADP does tend to slightly overestimate density, 
thus underestimating the percentage of body fat slightly (Collins & McCarthy, 2003).  The test-
retest variability in ADP is equal to about .8% body fat (Collins & McCarthy, 2003).  This is in 
comparison to .99% body fat variability in UWW (Collins & McCarthy, 2003).        
 ADP is performed by utilizing BOD POD technology (Figure 4). The BOD POD is a 
two-chambered machine that controls for pressure (How does the BOD POD work? 2013).  First, 
the subject is weighed on an extremely precise scale and then their volume is measured while 
sitting still within the BOD POD (How does the BOD POD work?, 2013).  By taking both the 
weight and the volume of the subject, their density can be determined.  The subject’s lung 
capacity is important in volumetric measures, but predicted values according to Siri and Brozek 
are typically used depending on the population being tested (e.g., Siri for Caucasians and Brozek 
for African Americans) (How does the BOD POD work?, 2013). 
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Figure 4. BOD POD technology used for Air Displacement Plethysmography.  Image from How 
does the BOD POD work?. (2013). Retrieved December 11, 2013, from 
http://ybefit.byu.edu/Portals/88/Documents/How%20Does%20The%20BOD%20POD%20Work.
pdf  
 
 In this study, we took measurements of body composition through each of these methods 
(i.e., BMI, WC, SAD, BIA, and ADP) and compared their accuracy to attempt to determine the 
best method for assessing obesity in the older adult population.  The measuring of body 
composition and overweight/obesity is vitally important because we want to be able to properly 
identify those individuals that are overfat, due to the health risks they face.  By continuing to rely 
upon BMI as the primary tool to assess obesity, a multitude of older adults may appear to be at a 
healthy and appropriate weight, while actually being overweight or obese.  By utilizing some of 
these other techniques to assess body composition, practitioners can improve their patient’s 
health outcomes (by being better aware and better suited to prevent negative disease outcomes 
associated with excess body fat and obesity).  This improvement can also have financial benefits 
for insurance companies, taxpayers, and even the patients by being able to address risk for 
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morbidities sooner and potentially reduce the amount of diseases and health-related 
consequences this population faces.     
METHODOLOGY 
 In this study we performed BMI, WC, SAD, bioelectrical impedance analysis, and air 
displacement plethysmography (via BOD POD) assessments on older adult males, aged over 50.  
These males were recruited via Campus Updates, fliers on Bowling Green State University 
campus, and fliers distributed in the community.  We expected to find ADP to be the most 
accurate method, as it is most similar to the gold standard of body composition methodologies 
(UWW).  Prior to the study, we did not postulate as to which of the remaining methodologies 
would be most appropriate and accurate in comparison to ADP, due to the variability in water 
and electrolyte concentrations and the variability in body shape.  However, it was expected that 
BMI would produce the least relevant and least appropriate results among all the techniques 
examined.   
 On a day of data collection, the tester arrived thirty minutes prior to the subject, in order 
to warm up and calibrate the BOD POD equipment.  The Analyze Hardware, Check Scale, 
Autorun, and Volume functions were run, in order to effectively prepare and calibrate the 
equipment.  Additionally, the scale associated with the BOD POD was calibrated once every two 
weeks.  Performing those functions helped to ensure the most accurate results from the ADP 
testing.   
 Upon the participant’s arrival to the testing facility, he was seated in the BOD POD 
room.  The subject was then asked to read the informed consent carefully and thoroughly.  The 
participant was encouraged to ask any questions regarding the informed consent.  Once all their 
questions were answered, the participant was given the option to either choose to sign the 
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informed consent and continue on with the scheduled testing, or refuse to sign the informed 
consent, no testing would be performed and they would be free to go. All subjects selected the 
former option and the testing commenced.  The informed consent is available in Appendix A.   
 Once the informed consent was signed by the participant, the participant completed a 
screening and demographic questionnaire.  If the participant met the study criteria of the 
screening and demographic questionnaire, they were asked to complete a physical activity 
questionnaire.  Reasons for exclusion from this research study include answering false to any of 
the ten questions on the front page of the questionnaire.  The physical activity questionnaire is 
available in Appendix B.  The screening and demographic questionnaire is attached in 
Appendix C.   
After the physical activity questionnaire was completed, the tester measured the 
participant’s blood pressure via auscultation, using a stethoscope and a sphygmomanometer.  
The blood pressure was measured at this point because the subject would have been in a seated 
position for a minimum of five minutes.  The blood pressure was measured in the participant’s 
non-dominant arm, with the arm lying relaxed on the table.  This blood pressure was recorded on 
the participant’s data collection sheet. The participant then remained seated and the tester 
measured the subject’s heart rate for one minute through their radial artery.  This value was also 
documented on the subject’s data collection sheet.  To review a blank copy of the data collection 
sheet, see Appendix D. 
In preparation for the ADP testing, the subject was then directed to change into the 
approved clothing for body composition testing.  The approved clothing standard for men is 
compression shorts and a swim cap.  The subject then removed shoes, socks, jewelry, and hair 
accessories and they changed into the compression shorts.  The purpose of this specific clothing 
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is to minimize the amount of error in the volumetric measurements taken by the BOD POD.  If 
the participant did not bring acceptable clothing to be worn for testing, approved clothing was 
provided to him.   
 Once appropriately attired for testing, the participant’s height was recorded to the nearest 
.1 centimeters.  For the height measurement the subject was required to stand with his back 
touching the stadiometer with their heels together (as indicated on the stadiometer’s baseplate).  
The subject’s head was held within the Frankfort plane (parallel to the ground).  The head plate 
was then lowered to the point in which it touches the subject’s head.  This value was also noted 
on the subject’s data collection sheet. 
 The subject was then directed to step away from the stadiometer and remain standing 
comfortably, standing up straight and breathing normally.  Using a Gulick tape, the tester first 
measured the WC of the subject at the narrowest point of the abdomen between the xiphoid 
process and the iliac crest.  The tape was then tightened to remove slack and was maintained at a 
parallel position to the floor without being twisted.  This resulting value was measured to the 
nearest .1 centimeter and recorded on the data collection sheet.  The tape was then placed along 
the subject’s transverse plane located at the umbilicus.  The tape was again tightened and made 
parallel, measured to the nearest 0.1 centimeter, and recorded on the data collection sheet. 
 Next, the tester and subject moved into the BIA room.  The printer and BIA machine 
were then turned on by the tester.  The subject’s information (age, gender, and height) was 
inputted into the BIA machine and placed in the kilogram and centimeter display mode while the 
subject stood on the silver panels of the BIA machine in his bare feet.  The subject was instructed 
to grasp the two upper extremity portions of the BIA machine with his thumbs placed on the 
small silver recording panels.  The BIA machine then performed the analysis and the results were 
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printed off.  This printed results sheet is kept with the data collection sheet, placed in the 
participant’s file folder. 
 After the BIA testing, the subject was taken back into the BOD POD room for the SAD 
measurements.  The subject went into a supine position on the examination table, and the SAD 
caliper was placed underneath the subject’s lumbar spine, directly in line with the subject’s 
umbilicus.  The subject was first asked to breathe normally, and then three separate 
measurements are taken while the subject exhales and holds his breath for approximately three 
seconds.  The top part of the caliper is lowered to touch the skin and a measurement is recorded 
to the nearest tenth of a centimeter.  The three measurements are logged on the data collection 
sheet. 
  The final test performed is the BOD POD analysis.  The subject’s basic demographic 
information was inputted into the BOD POD computer by the tester, including participant 
identification number, height, and date of birth.  The BOD POD was then calibrated one more 
time using the standardized volumetric cylinder.  The subject was directed to put on the Lycra 
swim cap.  This was important to ensure the accuracy of the volumetric measurement, due to the 
variability of trapped air associated with normal clothing and some hairstyles.  The subject 
subsequently stepped onto the BOD POD scale and had his weight measured and recorded on the 
data collection sheet.  Afterwards, the subject sat in the BOD POD chamber for two 
measurements of their volume.  If the data between the first two tests is variable past the 
accepted threshold, a third test is performed to standardize and ensure the accuracy of the 
measurement.  Each test lasted approximately 45 seconds. Upon successful completion, the 
subject changed back into his own clothing, was thanked, and escorted to the exit. 
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RESULTS 
 Data was collected from seven male subjects aged 57-68 years (Mean age of 61.57).  The 
below table describes the data collected from the subjects.  
Table 1. Description of Statistics of the Sample Population. Means and Standard Deviations. 
Descriptive Statistics 
  Mean 
Std. 
Deviation N 
Age                 (Years) 61.57 4.504 7 
Heart Rate        (Bpm) 70.00 11.255 7 
Systolic BP   (mm Hg) 130.86 12.851 7 
Diastolic BP  (mm Hg) 82.00 8.246 7 
BMI                 (kg/m
2
) 26.643 3.6251 7 
WC Narrow          (cm) 
92.886 8.7536 7 
WC Umbilicus      (cm) 
94.371 8.4929 7 
SAD (Avg.)          (cm) 22.633 2.4269 7 
BIA                   (%Fat) 22.829 3.1763 7 
ADP                 (%Fat) 25.657 5.7029 7 
  
Table 1 describes the mean values and standard deviations for each test performed.  In 
addition to these mean values and standard deviations, frequency tables were created to evaluate 
how each test stratified each individual into various risk categories particular to each test.  Below 
are charts that depict how subjects are stratified in accordance with each test.  These charts 
include risk stratification based on blood pressure (hypertension risk), BMI, WC (narrow), WC 
(umbilicus), SAD, BIA, and ADP (BOD POD).  Statistical analyses (including Pearson 
Correlations) were performed through SPSS software. 
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Figure 5. Risk Stratification based on blood pressure levels indicating potential hypertension 
(HTN) risk. 
  
Hypertension risk is determined by both the systolic (while the heart is pumping blood) 
and diastolic (while the heart rests between beats) blood pressure values.  Normal values for 
blood pressure are having a systolic blood pressure of less than 120 mm Hg and diastolic blood 
pressure of less than 80 mm Hg.  Pre-hypertension is classified as having a systolic blood 
pressure between 120-139 mm Hg and or a diastolic blood pressure of 80-89 mm Hg.  Stage I 
hypertension is classified as having a systolic blood pressure of 140-159 mm Hg and  a diastolic 
blood pressure of 90-99 mm Hg.  Stage II hypertension is classified as having a systolic blood 
pressure greater than 160 mm Hg or a diastolic blood pressure greater than100 mm Hg 
(American Heart Association, 2012).  As noted in Figure 1, two subjects were classified as 
having normal blood pressure, two subjects classified as pre-hypertensive, and three subjects as 
hypertensive. 
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Figure 6. Risk Stratification based on body mass index (BMI) scores.  Body mass index is a ratio 
of a person’s height and weight. 
  
Body mass index is calculated by dividing a subject’s bodyweight in kilograms by their 
height in meters squared.  Having a BMI of less than 18.5 kg/m
2
 classifies a subject as 
underweight.  A normal value for body mass index ranges from 18.5 kg/m
2
 to 24.9 kg/m
2
.  A 
body mass index from 25.0 kg/m
2
 to 29.9 kg/m
2
 classifies the subject as overweight.  A body 
mass index from 30.0 kg/m
2
 to 34.9 kg/m
2 
classifies the subject as being class I obese.  A body 
mass index from 35.0 kg/m
2
 to 39.9 kg/m
2
 classifies the subject as being class II obese.  A body 
mass index greater than 40.0 kg/m
2
 classifies the subject as being class III obese (Centers for 
Disease Control and Prevention, 2011) BMI stratified three subjects as normal, three subjects as 
overweight, and one subject as class I obese. 
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Figure 7. Risk stratification based on narrow waist circumference measurements.  This 
measurement was taken at the narrowest point of the abdomen between the xiphoid process and 
the iliac crest of the hip. 
 
 The two classifications for WC are either normal risk or high risk for negative health 
consequences.  A WC of less than 102 centimeters classifies the subject as normal risk.  A WC 
of greater than 102 centimeters classifies the subject as high risk (National Heart, Lung, and 
Blood Institute, 2000).  Note that the WC cutoff between normal and high risk is the same 
between WC measurements taken at the narrowest point and those taken at the umbilicus.   
The below graph, Figure 8, indicates the same classification of risk as Figure 7, but is 
based on measurements taken at the umbilicus.  Both WC measurement methodologies classified 
six subjects as normal risk and one subject as high risk. 
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Figure 8. Risk stratification based on the waist circumference measurement taken at the 
umbilicus. 
 
 
Figure 9. Risk Stratification based on sagittal abdominal diameter measurements.  Three 
measurements were taken and the average value was used. 
  
 SAD stratifies subjects into normal risk, borderline-high risk, and high risk categories for 
negative health consequences.  A SAD of less than 25.0 centimeters indicates normal risk.   A 
SAD between 25.0 centimeters and 30.0 centimeters indicates borderline-high risk.  A SAD 
greater than 30.0 centimeters indicates high risk.  According to SAD measurements taken in the 
study, six subjects were at normal risk, and one subject was at high risk. 
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Figure 10. Risk Stratification/Body Composition based on percentage body fat as determined by 
bioelectrical impedance analysis. 
 
 There are six classifications of body composition based on the percentage body fat of the 
subject.  Risky low body fat is a body fat percentage under 5.0.  A body fat percentage between 
5.0 and 8.9 is considered ultra-lean.  A body fat percentage between 9.0 and 12.9 is considered 
lean.  A body fat percentage between 13.0 and 20.9 is considered moderately lean.  A body fat 
percentage between 21.0 and 29.9 is considered excess fat. A body fat percentage greater than 
30.0 is considered risky high body fat (ACSM, 2014).  According to these classifications, the 
BIA results classify two subjects as moderately lean and five subjects as having excess body fat.   
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Figure 11. Risk Stratification/Body Composition based on percentage body fat as determined by 
the BOD POD through air displacement plethysmography. 
 
Similarly to BIA scales, ADP determines a subject’s percentage body fat using the same 
classification naming standards (ACSM, 2014).  As shown in Figure 7, one subject was 
classified as moderately lean, five subjects were classified as having excess fat, and one subject 
was classified as having risky high body fat. 
Table 2. Correlation Matrix between body mass index, waist circumference at its narrowest and 
at the umbilicus, and sagittal abdominal diameter. 
  BMI WC Narrow WC Umbilicus SAD 
BMI 1 
   WC Narrow 0.896 1 
  WC Umbilicus 0.868 0.995 1 
 SAD 0.921 0.976 0.970 1 
* All correlations significant at the p<0.05 level. 
Table 2 describes the most closely correlated and most significant methodologies.  A 
correlation matrix between all methodologies and measurements performed is available in 
Appendix E. 
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DISCUSSION 
 From this study’s findings there are three significant conclusions that can be drawn.  The 
first conclusion can be drawn from the discrepancies in health risk stratification between BMI 
and ADP’s determination of body fat percentage. BMI describes three subjects as normal weight, 
three subjects as overweight, and one subject as class I obese (see Figure 6).  In comparison, 
ADP describes one subject as moderately lean, five people as excess fat, and one person as risky 
high body fat (see Figure 11).  These two stratification methods show very different potential 
health outcomes of the test subjects.  If only using BMI as a means of risk stratification, 
approximately half of the subjects would appear to be at normal risk.  Using BMI would 
misclassify two of the seven subjects by underestimating their risk of developing negative health 
consequences.  This stresses the importance and need for the implementation of a body 
composition tool that actually assesses percent body fat on an individual basis.  BMI was not 
significantly correlated with ADP (r=.483, p=.273).  
 The traditional argument against BMI was that BMI will overestimate risk due to the 
subject’s increased amount of muscle mass.  This argument has been consistently validated in 
young adult male athletes.  However, in the older male population the inverse relationship is true.  
BMI is underestimating the risk of the population to develop negative health consequences.  This 
is an important finding, due to the continued growth of this population and the likelihood that 
this group’s obesity prevalence is being underrepresented.    
 Also of note in the study results, BIA and ADP differed slightly in their risk stratification, 
even though both base their risk classification on the subject’s body fat percentage.  BIA 
underestimated the percent body fat in comparison to air displacement plethysmography in one 
of the seven subjects.  This difference may be due to increased water weight often carried by 
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men as they age or due to various electrolyte and ion levels within the subjects.  Even with this 
slight differentiation, BIA was still much more closely related in risk stratification to ADP, when 
compared to BMI. BIA had a Pearson correlation of .746 and a p-value of .054 (approaching 
significance). 
 A second conclusion that can be drawn from results of this study is that a significant 
relationship between BMI, narrow WC, umbilicus WC and SAD was identified (see Table 2). 
When comparing BMI to the other methodologies of assessment listed in Table 2, the p-values 
were determined with narrow WC (p=.006), umbilicus WC (p=.012), and SAD (p=.004).  All of 
these methodologies are significant on the p 0<.05 (95% confidence) level.  Additionally, both 
WC measurements and SAD are significantly correlated on the p<0.01 (99% confidence) level.  
This is to be expected as they are all measuring the visceral fat of the abdomen.   
 The third result of note was that heart rate was significantly correlated with the 
percentage body fat as determined by BIA at the p=0.006 level (highly correlated with r=0.???).  
The p-value was equal to .006.  This is interesting because the p-value between heart rate and the 
percent body fat as determined by the BOD POD was not significant (p-value=.130).  In a larger 
sample size, it would be anticipated that heart rate would either be significant with both 
methodologies that calculate percentage body fat or not significant to either of the two methods. 
CONCLUSION AND RECOMMENDATIONS 
 This study has found that, as anticipated, BMI is the least accurate of all of the 
methodologies tested in assessing health risk for a male adult over age 50.  If feasible, a two 
compartment model that can distinguish between fat mass and fat-free mass (i.e., BIA or ADP) 
should be chosen over BMI, as well as being prioritized over the other anthropometric 
methodologies of WC and SAD for most accurate results.  However, BIA and ADP equipment 
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can be extremely expensive and thus not feasible in certain settings where funds are limited.  In 
these situations, combining one of the significantly correlated anthropometric measurements 
along with BMI may help to validate risk stratification better than body mass index alone.  
Because the WC measurements and SAD are so closely related, only one of these methods needs 
to be performed in conjunction with BMI.  By implementing different approaches, we may be 
able to better identify and target individuals at risk for negative health consequences, and 
therefore fight the obesity epidemic in our nation. 
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Appendix A 
Informed Consent for “Senior Health Study” 
Introduction: You are being invited to participate in the “Senior Health 
Study.” This project is collaboration between Dr. Amy Morgan, an 
associate professor of kinesiology, Dr. Mary-Jon Ludy, an assistant 
professor of clinical nutrition, Edward Kelley, a graduate student 
completing a master’s degrees in kinesiology, and Cody Smith, an 
honors undergraduate student. We are interested studying the body 
composition status of older community members. 
Purpose: The purpose of this study is to explore body composition 
measures in older populations. In general, the study will help to assess 
the need for better obesity classification standards in older Americans.  
Benefits of being a participant include:  
- A comprehensive body composition analysis testing session. 
- Access to results and expert feedback after data is collected. This 
will include your testing results, which would cost approximately 
$200 at a health club. 
 
Testing Date: 
1. Arrive at laboratory. 
 - You will arrive at Eppler South 124 at least 2-hours after exercise 
 and eating/drinking anything other than water. 
a. Sign informed consent document. 
a. You will read the informed consent document. 
b. You will ask any questions about participating in this study.   
c. After all your questions have been answered, you will have the 
option of:  
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 Signing the informed consent (meaning that you agree to participate in 
this study), or  
 Deciding not to participate.  
b. Screening and demographic questionnaire.  
You will complete a questionnaire asking about: Your sex, age, 
ethnic/racial background, height, weight, phone number, and email. 
(If applicable we will ask if you are claustrophobic) 
Upon completion of informed consent and pre-testing questionnaires 
testing will begin. 
 
Test Visit Procedures (45 minutes): 
1. You will arrive at Eppler South 124 at least 2-hours after exercise and 
 eating/drinking  anything other than water.  
2. You will sit while completing informed consent, demographic, and 
physical activity questionnaire.  
3. Your blood pressure will be measured by placing a cuff around your 
upper arm.  
4. You will dress in a swimsuit or tights shorts with sports bra (if 
applicable), swim cap, and  nose plugs for your body composition 
measurements.  
5. You will have your waist circumference measured by placing a 
measuring tape around  your waist.  
6. You will have your height measured while standing against the wall.  
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7. You will have your sagittal abdominal diameter measured while laying 
supine. 
8. You will have your body composition measured using 2 methods.  
 Method 1 (BOD POD): You will sit in an airtight chamber for 2-3 
brief measurements lasting approximately 45 seconds. You should not 
participate in this measurement if you are claustrophobic.  
 Method 2 (bioelectrical impedance): You will stand on an 
electronic scale and place your hands around handgrips. You should not 
participate in this measurement if you have a pacemaker or other 
artificial electrical medical device/electrical system.  
9. You will dress in your own clothes.  
After Data Collection  
You will have access to your testing results. Your testing results will be 
available to you and research team members can answer any questions 
regarding your results.   
Voluntary nature: Your participation is completely voluntary. You are 
free to withdraw at any time. You may decide to skip questions (or not 
do a particular task) or discontinue participation at any time without 
penalty. Deciding to participate or not will not affect your relationship 
with Bowling Green State University. 
Confidentiality: Your participation in this study will remain confidential. 
Hard copies of all data will be stored in a locked filing room. The 
principal investigator, co-investigators, and graduate student assistants 
will be the only people with access to the data. The hard- copies will be 
retained for 3 years after the project ends, after which they will be 
destroyed by shredding. Electronic files will be stored on a portable 
flash drive in password-protected documents and will not be destroyed. 
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The study will not be anonymous because it will be necessary to 
identify participants before each test, as well as track and analyze 
results. Your name will be used when signing consent forms, at the 
screening visit, and when entering data into computer hardware for 
body composition testing. You will receive a “subject ID” number, 
which will be used on all paper documents after screening. 
Risks: Risk may be encountered during body composition assessments 
and alcohol reporting. 
b. BOD POD: There is a risk that participants will experience anxiety 
and/or uneasiness  when placed in the confined windowed 
chamber. This procedure, involving 2-3 measurements of 
approximately 45 seconds, will be monitored by laboratory staff 
and can be discontinued at any point as necessary. The BOD POD 
also has a “panic button” that the subject may press at any point 
during the assessment to stop the test. To minimize this risk, 
potential participants reporting claustrophobia will be excluded at 
screening.  
c. Bioelectrical impedance analysis: There is a risk that the small 
electrical signal transmitted through bioelectrical impedance 
analysis (to measure resistance of body tissues to the electrical 
flow, and thus estimate body fat and muscle mass) will interfere 
with implanted electrical devices. To avoid this risk, potential 
participants who report having a pacemaker or other artificial 
electrical medical device/electrical system will be excluded at 
screening.  
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Contact information: If you have any questions about this research or 
your participation in this research, please contact the study 
investigators. 
Principal Investigator: Dr. Amy Morgan, Associate Professor School of 
HMSLS amorgan@bgsu.edu 419-372-0596 
Co-Investigator: Dr. Mary-Jon Ludy, Assistant Professor School of FCS 
mludy@bgsu.edu 419-372-6461 
Co-Investigator:  Edward Kelley,  Graduate Student School of HMSLS 
etkelle@bgsu.edu 419-372-0212 
You may also contact the Chair, Human Subjects Review Board 
hsrb@bgsu.edu, if you have any questions about your rights as a 
participant in this research. 
Thank you for your time. 
 
I have been informed of the purposes, procedures, risks and benefits of 
this study. I have had the opportunity to have all my questions 
answered and I have been informed that my participation is completely 
voluntary. I agree to participate in this research. 
_____________________________________ Participant Signature 
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Appendix B 
Name: ___________________________________ 
Subject ID: _________________________________  
Visit Date: _________________________________ 
PHYSICAL ACTIVITY QUESTIONNAIRE 
We are interested in finding out about the kinds of physical activities 
students do as part of their everyday lives. The questions will ask you 
about the time you spent being physically active in the last 7 days. 
Please answer each question even if you do not consider yourself to be 
an active person. Please think about the activities you do on campus, at 
work, to get from place to place, and in your spare time for recreation, 
exercise, or sport. 
Think about all the vigorous activities that you did in the last 7 days. 
Vigorous physical activities refer to activities that take hard physical 
effort and make you breathe much harder than normal. Think only 
about those physical activities that you did for at least 10 minutes at a 
time. 
1. During the last 7 days, on how many days did you do vigorous 
physical activities like heavy lifting, digging, aerobics, or fast 
bicycling? 
  _____ days per week   
 
 No vigorous physical activities   Skip to question 3  
2. How much time did you usually spend doing vigorous physical 
activities on one of those days?  
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  _____  hours per day  
  _____  minutes per day  
  ______ Don’t know/Not sure   
  
Think about all the moderate activities that you did in the 
last 7 days. Moderate activities refer to activities that take 
moderate physical effort and make you breathe somewhat 
harder than normal. Think only about those physical 
activities that you did for at least 10 minutes at a time.  
3. During the last 7 days, on how many days did you do moderate 
physical activities like carrying light loads, bicycling at a regular pace, or 
doubles tennis? Do not include walking. 
  _____ days per week  
 
  No moderate physical activities    Skip to question 5 
4. How much time did you usually spend doing moderate physical 
activities on one of those days? 
  _____  hours per day  
  _____  minutes per day 
 
  _____ Don’t know/Not sure    
 
Think about the time you spent walking in the last 7 days. This 
includes at work and at home, walking to travel from place to place, 
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and any other walking that you might do solely for recreation, sport, 
exercise, or leisure.  
5. During the last 7 days, on how many days did you walk for at least 10 
minutes at a time? 
    _____ days per week   
  No walking   Skip to question 7 
6. How much time did you usually spend walking on one of those days?  
  _____  hours per day  
  _____ minutes per day   
  _____ Don’t know/Not sure  
  The last question is about the time you spent sitting on 
weekdays during the last 7 days. Include time spent at work, 
at home, while doing course work and during leisure time. 
This may include time spent sitting at a desk, visiting friends, 
reading, or sitting or lying down to watch television.  
7. During the last 7 days, how much time did you spend sitting on a 
week day? 
  _____  hours per day  
  _____  minutes per day  
  _____ Don’t know/Not sure  
  Thank you for completing the physical activity 
questionnaire!  
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Appendix C 
Name: _________________________________  
Subject ID: ______________________________ 
Visit Date: ______________________________ 
SCREENING AND DEMOGRAPHIC QUESTIONNAIRE 
Please circle TRUE or FALSE for the following questions. 
 
TRUE   FALSE 1.  I am not claustrophobic. 
TRUE   FALSE 2.  I do not have a pacemaker or artificial electrical  
    medical device(s)/electrical system(s).   
TRUE   FALSE 3.  I am willing to attend 1 test visit lasting about 45  
    minutes each. 
TRUE   FALSE 4.  I am willing to answer questions about my physical  
    activity. 
TRUE   FALSE 5.  I am willing to have my blood pressure measured.  
TRUE   FALSE 6.  I am willing to have my weight measured.  
TRUE   FALSE 7.  I am willing to have my height measured.  
TRUE   FALSE 8.  I am willing to have my waist size measured. 
TRUE   FALSE 9.  I am willing to have my abdomen measured. 
TRUE   FALSE 10.  I am willing to wear a swimsuit or tight shorts with a  
    sports bra (if applicable) to have my muscle and  
    body fat measured. 
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Please fill-in or circle your answers to the following questions. 
11. Sex: ______ male; ______ female  
12. Age: ______ years  
13. Birthday (month/day/year): _________________________________  
14. Ethnic/Racial Background 
1. White/Caucasian (non-Hispanic)  
2. Asian/Pacific Islander  
3. Hispanic  
4. Black/African American  
5. American Indian/Alaskan  
6. Other (name): _______________________ 
7. Prefer not to answer  
15. Height: ______ inches  
16. Weight: ______ pounds  
17. Phone Number: _________________________ 
18. Email: _________________________________ 
 
Thanks for completing the screening and demographic 
questionnaire! 
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Appendix D 
Senior Health Study Data Collection Sheet 
 
Participant ID: ____________________ 
 
Resting Blood Pressure: ___________________ 
 
Height (cm):_____________________ 
 
Waist Circumference (Narrow):_________________________ 
 
Waist Circumference (Umbilicus):______________________ 
 
Bioelectrical Impedance Analysis (% fat):___________________ 
 
Sagittal Abdominal Diameter (cm): Trial 1_____   Trial 2_____   Trial 3_____ 
 
BodPod: Fat Mass (kg)________  Lean Body Mass (kg)_________ 
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Appendix E 
Pearson correlation coefficients 
         
            Correlations 
  Age HR 
Sys 
BP 
Dia 
BP BMI 
WC 
Narrow 
WC 
Umbilicus 
SAD 
AVG. 
BIA 
%FAT 
BOD 
POD 
%FAT 
Age Pearson Correlation 1 -.270 .491 .386 -.479 -.264 -.183 -.166 -.512 -.052 
Sig. (2-tailed)   .559 .263 .393 .277 .567 .694 .722 .241 .912 
HR Pearson Correlation -.270 1 -.088 .295 .570 .285 .238 .435 .901
**
 .629 
Sig. (2-tailed) .559   .852 .521 .182 .536 .608 .330 .006 .130 
Sys 
BP 
Pearson Correlation .491 -.088 1 .755
*
 -.189 .010 .062 .024 -.155 .461 
Sig. (2-tailed) .263 .852   .050 .685 .983 .896 .959 .740 .298 
Dia 
BP 
Pearson Correlation .386 .295 .755
*
 1 .087 .297 .325 .339 .277 .702 
Sig. (2-tailed) .393 .521 .050   .852 .518 .478 .457 .547 .079 
BMI Pearson Correlation -.479 .570 -.189 .087 1 .895
**
 .867
*
 .918
**
 .669 .483 
Sig. (2-tailed) .277 .182 .685 .852   .006 .012 .004 .101 .273 
WC 
Narrow 
Pearson Correlation -.264 .285 .010 .297 .895
**
 1 .995
**
 .974
**
 .419 .428 
Sig. (2-tailed) .567 .536 .983 .518 .006   <0.001 <0.001 .350 .338 
WC 
Umbilicus 
Pearson Correlation -.183 .238 .062 .325 .867
*
 .995
**
 1 .970
**
 .370 .441 
Sig. (2-tailed) .694 .608 .896 .478 .012 <0.001   <0.001 .414 .323 
SAD 
AVG. 
Pearson Correlation -.166 .435 .024 .339 .918
**
 .974
**
 .970
**
 1 .490 .484 
Sig. (2-tailed) .722 .330 .959 .457 .004 .000 <0.001   .265 .271 
BIA 
%FAT 
Pearson Correlation -.512 .901
**
 -.155 .277 .669 .419 .370 .490 1 .746 
Sig. (2-tailed) .241 .006 .740 .547 .101 .350 .414 .265   .054 
BOD 
POD 
%FAT 
Pearson Correlation -.052 .629 .461 .702 .483 .428 .441 .484 .746 1 
Sig. (2-tailed) .912 .130 .298 .079 .273 .338 .323 .271 .054   
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 
 
 
 
 
